SCHEMBL14745815

SCHEMBL14745815

CCc1c(-c2ccc(Br)cc2)[nH]c(=O)c(C(=O)O)c1O.CCc1cc(C(=O)O)c(=O)[nH]c1-c1ccc(I)cc1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 3/20 0.41
PDE3A Q14432 3/20 0.41
PRNP P04156 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
PPARG P37231 1/20 0.34
HIF1A Q16665 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
NR2E3 Q9Y5X4 1/20 0.34
NCOR2 Q9Y618 1/20 0.34
CNR2 P34972 1/20 0.31
TNIK Q9UKE5 1/20 0.31
SIRT1 Q96EB6 1/20 0.30
MPL P40238 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14745498 0.91 PDE3B (0.41) PDE3BPDE3APRNPCYP1A2CYP2C9
SCHEMBL14740980 0.86 PDE3B (0.41) PDE3BPDE3APRNPCYP1A2CYP2C9
SCHEMBL14741096 0.85 AURKA (0.36) PDE3BPDE3APPARGTNIK
SCHEMBL14741243 0.84 PDE3B (0.50) PDE3BPDE3APRNPCYP1A2CYP2C9
SCHEMBL14745816 0.83 PDE3B (0.43) PDE3BPDE3APRNPCYP1A2CYP2C9
SCHEMBL14745238 0.83 SERPINE1 (0.42) PDE3BPDE3A
SCHEMBL17595254 0.83 MEN1 (0.38) PDE3BPDE3AHIF1ANPSR1CNR2
SCHEMBL14741107 0.82 KDM4E (0.41) PDE3BPDE3ARXFP1CNR2TNIK
SCHEMBL17594868 0.80 KIF11 (0.38) PDE3BPDE3ASIRT1
SCHEMBL14745819 0.80 GSK3B (0.43) PDE3BPDE3ARXFP1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016039936-A2 MONOCYCLIC SUBSTITUTED 2-PYRIDINONE ANTIBACTERIAL COMPOUNDS PTC THERAPEUTICS, INC. (US) 2016-03-17 WO claimed
EP-2750505-A1 ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE PTC Therapeutics, Inc. (US) 2014-07-09 EP disclosed
WO-2013033240-A1 ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE PTC THERAPEUTICS, INC. (US) 2013-03-07 WO disclosed